DE2432049A1 - COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL AND ITS USE - Google Patents
COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL AND ITS USEInfo
- Publication number
- DE2432049A1 DE2432049A1 DE2432049A DE2432049A DE2432049A1 DE 2432049 A1 DE2432049 A1 DE 2432049A1 DE 2432049 A DE2432049 A DE 2432049A DE 2432049 A DE2432049 A DE 2432049A DE 2432049 A1 DE2432049 A1 DE 2432049A1
- Authority
- DE
- Germany
- Prior art keywords
- membrane
- composite according
- composite
- porous material
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012528 membrane Substances 0.000 title claims description 45
- 239000002131 composite material Substances 0.000 title claims description 26
- 239000000463 material Substances 0.000 title claims description 4
- 239000000243 solution Substances 0.000 claims description 23
- 235000015097 nutrients Nutrition 0.000 claims description 18
- 239000011148 porous material Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 8
- 230000005764 inhibitory process Effects 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000123 paper Substances 0.000 claims description 3
- QSXWFQWZUMZZSP-UHFFFAOYSA-N 2-(4-nitrophenyl)propane-1,1,1-triol Chemical compound OC(O)(O)C(C)C1=CC=C([N+]([O-])=O)C=C1 QSXWFQWZUMZZSP-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229930024421 Adenine Natural products 0.000 claims description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
- 229930064664 L-arginine Natural products 0.000 claims description 2
- 235000014852 L-arginine Nutrition 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 229930182844 L-isoleucine Natural products 0.000 claims description 2
- 239000004395 L-leucine Substances 0.000 claims description 2
- 235000019454 L-leucine Nutrition 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000020 Nitrocellulose Substances 0.000 claims description 2
- NCXMLFZGDNKEPB-UHFFFAOYSA-N Pimaricin Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCC(C)OC(=O)C=CC2OC2CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 NCXMLFZGDNKEPB-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 2
- 229960000643 adenine Drugs 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims description 2
- 229960003255 natamycin Drugs 0.000 claims description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 229920001220 nitrocellulos Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- 229940035893 uracil Drugs 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims 1
- 229920003043 Cellulose fiber Polymers 0.000 claims 1
- 235000019743 Choline chloride Nutrition 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 229930195722 L-methionine Natural products 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 244000052616 bacterial pathogen Species 0.000 claims 1
- 229960002079 calcium pantothenate Drugs 0.000 claims 1
- 229960003178 choline chloride Drugs 0.000 claims 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims 1
- 229960004452 methionine Drugs 0.000 claims 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims 1
- 229960002901 sodium glycerophosphate Drugs 0.000 claims 1
- -1 sodium glycerophosphate pentahydrate Chemical class 0.000 claims 1
- 229940054269 sodium pyruvate Drugs 0.000 claims 1
- 238000007711 solidification Methods 0.000 claims 1
- 230000008023 solidification Effects 0.000 claims 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 1
- 229960000344 thiamine hydrochloride Drugs 0.000 claims 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims 1
- 239000011747 thiamine hydrochloride Substances 0.000 claims 1
- 239000011734 sodium Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000012009 microbiological test Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/10—Supported membranes; Membrane supports
- B01D69/106—Membranes in the pores of a support, e.g. polymerized in the pores or voids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
Dr.Ho/ADr Ho / A
C. H. Boehringer Sohn, Ingelheim am RheinC. H. Boehringer Sohn, Ingelheim am Rhein
und
Sartorius-Membranfliter GmbHand
Sartorius membrane filter GmbH
Göttingen, Weender Landstraße 94 - 102Göttingen, Weender Landstrasse 94-102
Verbund aus Membranfiltern und porösem Material und seine Verwendung Composite of membrane filters and porous material and its use
Die Erfindung betrifft einen Verbund aus Membranfiltern und porösem Material, das Verfahren zu dessen Herstellung sowie die Verwendung als Träger von Nährmedien für mikrobiologische Untersuchungen.The invention relates to a composite of membrane filters and porous material, the method for its production and the use as a carrier of nutrient media for microbiological investigations.
Membranfilter werden in abgestufter Durchlässigkeit nach verschiedenen Methoden und aus verschiedenen Stoffen hergestellt. Sie bestehen z. B. aus einer dünnen Haut kolloidaler Lösungen, z. B. Gelatine, Collodium, Kieselsäure, Celluloseestern oder Cellulose, die beim Verdunsten und Koagulieren ein Gerüst aufbauen, dessen Hohlräume eine schwammartige Struktur bilden. Die Querschnitte der Poren lassen sich durch die Herstellungsweise weitgehend variieren, so daß man z.B. Bakterien und sogar Teilchen bis zu molekularer Größe absieben kann.Membrane filters are graded according to different permeability Methods and made from different fabrics. They consist e.g. B. from a thin skin of colloidal solutions, z. B. gelatine, collodion, silicic acid, cellulose esters or cellulose, which build up a framework when evaporating and coagulating, the cavities of which form a sponge-like structure. The cross-sections of the pores can be determined by the manufacturing method vary widely, so that e.g. bacteria and even particles up to molecular size can be sieved off.
509884/0582509884/0582
Membranfilter müssen bei der Anwendung normalerweise abgestützt werden, bei größeren Dimensionen meist auf Siebplatten oder Fritten, da sie für sich mechanisch nicht hinreichend fest sind.Membrane filters normally have to be supported during use, with larger dimensions usually on sieve plates or frits, as they are not mechanical in themselves are sufficiently firm.
Bei vielen Anwendungszwecken wäre ein fester Verbund aus Membranfilter und einer porösen Unterlage sehr erwünscht, wobei die Eigenschaften des Membranfilters einerseits und die Eigenschaften der porösen Unterlage andererseits jeweils vollständig und unverändert erhalten bleiben sollen.For many purposes, a solid composite of membrane filter and a porous base would be very desirable, wherein the properties of the membrane filter on the one hand and the properties of the porous substrate on the other hand should be retained completely and unchanged.
Es ist bekannt, Klebstoff zum Aufkleben des Membranfilters auf eine poröse Unterlage zu verwenden, was jedoch den Nachteil hat, daß der Klebstoff in nicht vorhersagbarer Form die Eigenschaften des Systems Membranfilter/poröse Unterlage beeinflussen kann. Es ist auch bekannt, mit einer Lösung, aus der sich beim Trocknen ein Membranfilter bildet, eine poröse Unterlage zu tränken, so daß sich die Membranschicht zumindest teilweise innerhalb des porösen Materials bildet. Das so entstehende Produkt weist aber andere Eigenschaften auf, als die Einzelkomponenten. Dies betrifft vor allem die Oberfläche, die nicht mehr die glatte, für viele Arbeiten erforderliche Membranfilteroberfläche aufweist, sondern die Struktur der porösen Unterlage abbildet. It is known to use adhesive to glue the membrane filter to a porous substrate, but this has the disadvantage that the adhesive can influence the properties of the membrane filter / porous substrate system in an unpredictable manner. It is also known to soak a porous substrate with a solution from which a membrane filter is formed during drying, so that the membrane layer is at least partially formed within the porous material. But the so obtained product has different properties than the individual components. This applies above all to the surface, which no longer has the smooth membrane filter surface required for many jobs, but rather reproduces the structure of the porous base.
Wenn es sich bei der Unterlage um eine mit Nährmedien getränkte und getrocknete poröse Unterlage, beispielsweise eine Kartonscheibe handelt, die für differenzierte bakteriologische Hemmtests verwendet werden soll, ist angrenzend an die poröse Unterlage ein Membranfilter erforderlich. Dabei ist es weder angängig, einen Verbund durch Verkleben herzustellen noch das poröse Material mit dem das If the support is a porous support impregnated with nutrient media and dried, for example a cardboard disc, which is to be used for differentiated bacteriological inhibition tests, a membrane filter is required adjacent to the porous support. It is neither possible to create a bond by gluing nor to use the porous material with the that
509884/0582509884/0582
Membranfilter bildenden Material zu tränken, da einerseits die Klebstoffschicht die Diffusion der Nährstoffe zwischen poröser Unterlage und Membranfilter in nicht vorhersehbarer Weise beeinflußt, andererseits beim Fehlen der reinen, glatten Membranoberfläche beispielsweise keine konzentrischen Hemmhof-Ringe beim Antibioticatest entstehen.To soak membrane filter forming material, as on the one hand the Adhesive layer influences the diffusion of nutrients between the porous substrate and the membrane filter in an unpredictable way, on the other hand, in the absence of a pure, smooth membrane surface, for example no concentric Hemmhof rings arise during the antibiotic test.
Die Erfindung hat sich daher die Aufgabe gestellt, einen Verbund-Membranfilter/poröse Unterlage zu erzielen, bei welchem die Eigenschaften der beiden Komponenten voll erhalten bleiben und die Nachteile des Standes der Technik vermieden werden.The invention has therefore set itself the task of a To achieve composite membrane filter / porous base in which the properties of the two components are fully preserved remain and the disadvantages of the prior art are avoided.
Ein derartiger Verbund wird dadurch erhalten, daß ein Membranfilter auf der Basis poJLymerer Substanzen während der Gelierung der polymeren Membranbildner mit der porösen Unterlage in Kontakt gebracht und darauf verfestigt wird.Such a composite is obtained in that a Membrane filters based on polymeric substances during the gelation of the polymeric membrane formers is brought into contact with the porous substrate and solidified thereon.
Dabei entsteht der eingangs geschilderte Verbund aus Membranfilter und poröser Unterlage. Mit einem solchen Verbund lassen sich beispielsweise bei bakteriologischen Hemmtests nicht nur qualitative sondern sogar quantitative Aussagen machen.This creates the composite of membrane filters described at the beginning and porous base. Such a composite can be used, for example, in bacteriological inhibition tests make not only qualitative but even quantitative statements.
Gemäß einer speziellen Ausführungsform kann ein derartiger Verbund wie folgt hergestellt werden:According to a special embodiment, such Composite can be produced as follows:
Auf ein endloses, hochpoliertes Band wird in bekannter Weise eine Lösung aufgetragen, die zur Membranbildung befähigt ist. Als Membranbildner kommen insbesondere Cellulosenitrat, Celluloseacetat, Gelatine, PVC, PVA, Polyamid oder Alginat in Frage.A solution capable of forming a membrane is applied in a known manner to an endless, highly polished belt. Cellulose nitrate, cellulose acetate, gelatin, PVC, PVA, polyamide or alginate are particularly suitable as membrane formers.
Die aufgetragene Lösung wird durch bestimmte Klimazonen mit Hilfe des sich bewegenden Bandes geführt, z.B. wie inThe applied solution is guided through certain climatic zones with the help of the moving belt, e.g. as in
509884/0582509884/0582
DT-PS 1 017 596 beschrieben. Während dieses Prozesses verdampfen die Lösungsmittel, und zum Schluß erhält man als Festsubstanz ein poröses flächiges Gebilde, nämlich das Membranfilter. Zwischen der Phase der Lösung und dem festen Filter wird ein Stadium durchlaufen, in dem der polymere Membranbildner als Gel vorliegt.DT-PS 1 017 596 described. During this process, the solvents evaporate, and as a result, Solid substance a porous flat structure, namely the membrane filter. Between the phase of the solution and the solid The filter goes through a stage in which the polymeric membrane former is present as a gel.
Bringt man während dieses Stadiums eine poröse Unterlage, z.B. ein Band aus Karton, vorsichtig in Kontakt mit diesem Gel, so haftet das sich bildende Filter fest an diesem porösen Material und verfestigt sich darauf. Nach Beendigung des Fertigungsprozesses liegen sowbhl das Membranfilter wie auch die poröse Unterlage zwar im Verbund jedoch deutlich erkennbar in ihrer bisherigen unveränderten Form vor. Das äußert sich vor allem in der völlig einwandfreien Membranoberflache.If you bring a porous pad during this stage, E.g. a tape made of cardboard, carefully in contact with this gel, so the filter that is formed adheres firmly to it porous material and solidifies on it. After completion of the manufacturing process, the membrane filter is in place as well as the porous base, although in the composite, clearly recognizable in its previous unchanged form. This is particularly evident in the perfectly flawless membrane surface.
In entsprechender Weise kann eine zweite Membran auf die andere Seite des porösen Materials aufgebracht werden.In a corresponding manner, a second membrane can be applied to the other side of the porous material.
Die Haftung der beiden Komponenten aneinander ist sehr gut und ohne äußere Einwirkung erfolgt keine Trennung von poröser Unterlage und Membranfilter. Die Haftung kann nach Wunsch mehr oder weniger fest ausgebildet werden, je nachdem ob der Kontakt zwischen porösem Material und Membrangel mehr zu Anfang oder gegen das Ende des Gelzustandes des membranbildenden Materials hergestellt wird.· . T The two components adhere very well to one another and the porous base and membrane filter are not separated without external influence. The adhesion can be developed more or less firmly as desired, depending on whether the contact between the porous material and the membrane gel is made more at the beginning or towards the end of the gel state of the membrane-forming material. T
Der erfindungsgemäße Verbund aus Membranfilter und porösem Material, besonders Karton von etwa 1 bis 2 mm Stärke, eignet sich vor allem für mikrobiologische Teste, bei denen die Ausbildung scharf begrenzter, kreisrunder Hemmhöfe nötig oder erwünscht ist. Der Verbund wird dazu mit einer üblichen The composite according to the invention of membrane filter and porous material, especially cardboard about 1 to 2 mm thick, is particularly suitable for microbiological tests in which the formation of sharply delimited, circular zones of inhibition is necessary or desired. The network is to do this with a usual
509884/0582509884/0582
Nährlösung für Mikroorganismen imprägniert und übernimmt im wesentlichen die Funktion solcher Mittel wie Agar-Agar oder Gelatine, die üblicherweise zur Verfestigung von Nährböden verwendet werden.Impregnated nutrient solution for microorganisms and essentially takes over the function of such agents as agar or agar Gelatins, which are commonly used to solidify nutrient media.
Der imprägnierte Verbund (Nährkarton) kann nach Sterilisation unmittelbar für mikrobiologische Zwecke verwendet werden. Es ist jedoch auch möglich, den imprägnierten Verbund zu trocknen, in geeignete Formkörper, z.B. Kreisscheiben, zu zerschneiden und sterilisiert und steril verpackt aufzubewahren. Zu gewünschter Zeit kann durch Anfeuchten mit sterilem W .sser rasch ein in üblicher Weise verwendbarer Nährboden hergestellt werden. Die bewachsenen Nährkartons können gegebenenfalls nach Anfärben getrocknet und nach Überziehen mil: einer Folie als dauerhaftes Dokument aufbewahrt werden.The impregnated composite (nutrient card) can be used for microbiological purposes immediately after sterilization. It however, it is also possible to dry the impregnated composite, to cut it into suitable shaped bodies, e.g. circular disks and to be stored in a sterilized and sterile packaging. At the desired time, by moistening with sterile water, quickly a culture medium that can be used in the usual way can be produced. The overgrown nutrient cards can, if necessary, after staining dried and after covering with mil: a film as permanent Document to be retained.
Die Vorteile des erfindungsgemäßen Verbunds zeigen sich besonders bei solchen mikrobiologischen Testen, bei denen sich durch reproduzierbare Eigenschaften des Nährbodens eine Standardisierung der Teste ermöglichen läßt.The advantages of the composite according to the invention are particularly evident in those microbiological tests in which allows standardization of the tests through reproducible properties of the nutrient medium.
Dies gelingt besonders dann, wenn synthetische Nährmedien verwendet werden, d.h. Nährmedien, die aus definierten Verbindungen zusammengesetzt sind und nicht aus sonst gebräuchlichen Stoffgemischen (Peptone, Fleischextrakt, Hefeextrakt) und weiteren Zusätzen bestehen.This is particularly successful when synthetic nutrient media are used, i.e. nutrient media made up of defined compounds are composed and not of otherwise common substance mixtures (peptones, meat extract, yeast extract) and other additives.
Ein solches bynthetisches Nährmedium kann wie folgt zusammengesetzt sein:Such a bynthetic nutrient medium can be composed as follows be:
509884/0582509884/0582
Lösung I:Solution I:
BestandteileComponents
g/Literg / liter
50988 L/058250988 L / 0582
Lösung II;Solution II; BestandteileComponents
D-Glucose Inosit Cholin-Cl Nikotinsäureamid Thiamin-HCl Riboflavin ■ Pyridoxin-HCl Pantothensäure-Ca-Salz Folsäure Biotin Na-GIycerophosphat * 5 H p-Nitrophenylpropantriol Pimaricin Aqua dest.D-glucose inositol choline-Cl Nicotinamide Thiamine HCl Riboflavin ■ Pyridoxine HCl pantothenic acid calcium salt folic acid Biotin Na glycerophosphate * 5 H p-Nitrophenylpropane triol Pimaricin Aqua dest.
g/Literg / liter *)*)
1,98 0,011 0,014 0,011 0,01 0,001 0,006 0,01 0,009 0,0002 1,OA 0,005 0,1049 50,0 ml1.98 0.011 0.014 0.011 0.01 0.001 0.006 0.01 0.009 0.0002 1, OA 0.005 0.1049 50.0 ml
Lösung III:Solution III:
10 Jfige wäßrige Natronlauge 10 Jfige aqueous sodium hydroxide solution
Die Angaben beziehen sich auf diejenige Menge destillierten Wassers, die für die Herstellung der Lösungen I und II insgesamt verwendet werden, im vorliegenden Beispiel also 950 ml plus 50 ml.The data relate to the amount of distilled water that is used in total for the preparation of solutions I and II, in the present example 950 ml plus 50 ml.
5098B4/05825098B4 / 0582
1. Die Ingrediezien unter I werden in 950 ml dest. Wasser aufgelöst und 20 Minuten bei 121°C im Autoklav sterilisiert.1. The ingredients under I are distilled in 950 ml. Dissolved water and sterilized in an autoclave at 121 ° C for 20 minutes.
2. Die Glucose, Vitamine und Wuchsstoffe unter II werden2. The glucose, vitamins and growth substances under II are
in 50 ml dest. Wasser aufgelöst und durch Sterilfiltration über Membranfilter, Porengröße 0,22/Um, entkeimt.in 50 ml dist. Dissolved water and sterilized by sterile filtration through a membrane filter, pore size 0.22 / µm.
3. Die 10 %ige Natronlauge wird 20 Minuten bei 1210C im Autoklav sterilisiert.3. The 10% sodium hydroxide solution is sterilized in an autoclave at 121 ° C. for 20 minutes.
4. Lösung I und II werden jeweil's auf 55°C erwärmt, dann zusammengegeben; mit Hilfe von Lösung III wird der pH-Wert bei 47°C auf 7,2 eingestellt.4. Solution I and II are each heated to 55 ° C, then put together; the pH value is adjusted to 7.2 at 47 ° C. with the aid of solution III.
Die Mengen der Bestandteile in den Lösungen I und II können auch anders gewählt werden. Sie können beispielsweise auf etwa die Hälfte reduziert oder verdoppelt werden. Im allgemeinen ist es jedoch nicht zweckmäßig, einen Bestandteil, z.B. eine Aminosäure ganz wegzulassen oder das pH der Mischung wesentlich zu ändern. Die Verwendung der Medien in einem standardisierten Test ist nur möglich, soweit die Abweichungen keinen wesentlichen Einfluß auf das Wachstum der Mikroorganismen und damit auf die Größe der beim Test entstehenden Hemmhöfe hat.The amounts of the constituents in solutions I and II can also be chosen differently. For example, you can can be reduced to about half or doubled. In general, however, it is not advisable to To omit an ingredient, for example an amino acid, or to change the pH of the mixture significantly. The usage the media in a standardized test is only possible insofar as there are no deviations essential influence on the growth of the microorganisms and thus on the size of the zones of inhibition arising during the test Has.
Der Test kann in folgender Weise durchgeführt werden:The test can be carried out in the following ways:
509884/0582509884/0582
Der mit der Nährlösung imprägnierte Verbund (Kreisscheibe entsprechenden Durchmessers) wird mit der Membranschicht nach oben in eine Petrischale gelegt und mit einer bestimmten Menge der zu untersuchenden Probe (gegebenenfalls nach Verdünnung) beimpft. Dann werden Filterpapierblättchen von etwa 4 mm Durchmesser, die mit bestimmten Mengen antimikrobieller Wirkstoffe (Antibiotika, Sulfonamide) beladen sind, auf der Membran verteilt und die Petrischale etwa 16 bis 24 Stunden bei einer bestimmten Temperatur (z.B. 36 * I0C) bebrütet.The composite impregnated with the nutrient solution (circular disk of appropriate diameter) is placed with the membrane layer facing up in a Petri dish and inoculated with a certain amount of the sample to be examined (if necessary after dilution). Then filter paper sheets of about 4 mm diameter, which are loaded with certain amounts of antimicrobial agents (antibiotics, sulfonamides), are distributed on the membrane and the Petri dish is incubated for about 16 to 24 hours at a certain temperature (e.g. 36 * I 0 C).
Bei einer bestimmten Wirkstoffbeladung auf den Testblättchen besteht (bei gegebener, in üblicher Weise zu ermittelnden) Keimdichte ein Zusammenhang zwischen Hemmhofdurchmesser und minimaler Hemmkonzentration des Jeweiligen Wirkstoffs. Andererseits ist von den gebräuchlichen Wirkstoffen der maximal erreichbare bzw. therapeutisch zulässige Blutspiegel bekannt. Es ist daher möglich, aufgrund des Hemmhofdurchmessers die therapeutische Verwendbarkeit eines antimikrobiellen Wirkstoffs abzuschätzen.If there is a certain drug load on the test paper (with a given, to be determined in the usual way) Germ density a relationship between the diameter of the inhibition zone and the minimum inhibitory concentration of the respective active ingredient. On the other hand, of the active ingredients in use, the maximum achievable or therapeutically permissible blood level is known. It is therefore possible, due to the diameter of the inhibition zone, the therapeutic utility to estimate an antimicrobial agent.
Wird der Test mit standardisierter Nährlösung unter standardisierten Bedingungen durchgeführt, so werden mit dem erfindungsgemäßen Verbund reproduzierbare Ergebnisse erhalten. Mit bekannten vergleichbaren Mitteln, beispielsweise membranbeschichteten Kartons nach der deutschen Offenlegungsschrift 2 320 946, ist das nicht möglich. Ein weiteres Testverfahren, bei dem Nährkartons gemäß der Erfindung mit besonderem Vorteil verwendet werden können, ist in der deutschen Patentanmeldung P 23 Ol 211 bzw. der niederländischen Anmeldung 74 00336 beschrieben.If the test is carried out with standardized nutrient solution under standardized conditions, with the composite according to the invention obtained reproducible results. With known comparable means, for example membrane-coated cardboard according to the German Offenlegungsschrift 2 320 946, this is not possible. Another test method in which nutrient cards according to the invention can be used with particular advantage, is described in the German patent application P 23 Ol 211 and the Dutch application 74 00336.
509884/0582509884/0582
Claims (10)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742432049 DE2432049B2 (en) | 1974-07-04 | 1974-07-04 | METHOD FOR PRODUCING A COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL COMPOSITE, AND METHOD OF USING IT |
| IT50329/75A IT1040799B (en) | 1974-07-04 | 1975-07-02 | LAMINATE CONSISTING OF MEMBRANE FILTERS AND A POOSOUS MATERIAL AND RELATIVE USE |
| LU72885A LU72885A1 (en) | 1974-07-04 | 1975-07-02 | |
| BE157955A BE830972A (en) | 1974-07-04 | 1975-07-03 | ASSEMBLY OF FILTER MEMBRANES AND POROUS MATERIAL AND ITS USE |
| NL7507924A NL7507924A (en) | 1974-07-04 | 1975-07-03 | COMPOSITE PRODUCT OF MEMBRANE FILTERS AND POROUS MATERIAL, ITS PREPARATION AND USE. |
| DK301475A DK301475A (en) | 1974-07-04 | 1975-07-03 | CONTINUOUS ADHESIVE FREE UNIT CONSISTING OF A MEMBRANE FILTER AND A POROST MATERIAL |
| FR7521090A FR2276859A1 (en) | 1974-07-04 | 1975-07-04 | Nutrient support for microbiological investigations - by contacting polymeric membrane filter in gel state with porous support material |
| US05/689,792 US4042733A (en) | 1974-07-04 | 1976-05-25 | Forming solid, adhesive-free composite of membrane filters and cellulosic cardboard |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742432049 DE2432049B2 (en) | 1974-07-04 | 1974-07-04 | METHOD FOR PRODUCING A COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL COMPOSITE, AND METHOD OF USING IT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2432049A1 true DE2432049A1 (en) | 1976-01-22 |
| DE2432049B2 DE2432049B2 (en) | 1977-07-07 |
Family
ID=5919649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19742432049 Withdrawn DE2432049B2 (en) | 1974-07-04 | 1974-07-04 | METHOD FOR PRODUCING A COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL COMPOSITE, AND METHOD OF USING IT |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE830972A (en) |
| DE (1) | DE2432049B2 (en) |
| DK (1) | DK301475A (en) |
| FR (1) | FR2276859A1 (en) |
| IT (1) | IT1040799B (en) |
| LU (1) | LU72885A1 (en) |
| NL (1) | NL7507924A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0085166A1 (en) * | 1981-12-30 | 1983-08-10 | New York Blood Center, Inc. | A filter and a process for the preparation thereof |
| US4640778A (en) * | 1981-12-30 | 1987-02-03 | New York Blood Center, Inc. | Fibrin gel-containing filter |
| DE3920562C1 (en) * | 1989-06-23 | 1990-07-12 | Amafilter Membrantechnik Gmbh, 3012 Langenhagen, De | Plate membrane used in micro- and ultra-filtration - obtd. by forming polymer membrane layer on rigid and porous plate through phase inversion process |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3707054A1 (en) * | 1987-03-05 | 1988-09-15 | Akzo Gmbh | METHOD FOR PRODUCING A TWO-LAYER MEMBRANE |
-
1974
- 1974-07-04 DE DE19742432049 patent/DE2432049B2/en not_active Withdrawn
-
1975
- 1975-07-02 IT IT50329/75A patent/IT1040799B/en active
- 1975-07-02 LU LU72885A patent/LU72885A1/xx unknown
- 1975-07-03 BE BE157955A patent/BE830972A/en unknown
- 1975-07-03 NL NL7507924A patent/NL7507924A/en unknown
- 1975-07-03 DK DK301475A patent/DK301475A/en unknown
- 1975-07-04 FR FR7521090A patent/FR2276859A1/en not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0085166A1 (en) * | 1981-12-30 | 1983-08-10 | New York Blood Center, Inc. | A filter and a process for the preparation thereof |
| US4640778A (en) * | 1981-12-30 | 1987-02-03 | New York Blood Center, Inc. | Fibrin gel-containing filter |
| DE3920562C1 (en) * | 1989-06-23 | 1990-07-12 | Amafilter Membrantechnik Gmbh, 3012 Langenhagen, De | Plate membrane used in micro- and ultra-filtration - obtd. by forming polymer membrane layer on rigid and porous plate through phase inversion process |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2432049B2 (en) | 1977-07-07 |
| BE830972A (en) | 1976-01-05 |
| DK301475A (en) | 1976-01-05 |
| NL7507924A (en) | 1976-01-06 |
| LU72885A1 (en) | 1976-11-11 |
| IT1040799B (en) | 1979-12-20 |
| FR2276859A1 (en) | 1976-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69506781T2 (en) | Cell culture substrates and methods of using them | |
| DE69531821T2 (en) | MULTILAYER ALGINATE COATINGS OF BIOLOGICAL TISSUE FOR TRANSPLANTATION | |
| DE3504724C2 (en) | Method for encapsulating a material to be encased | |
| DE3837226C2 (en) | Perfusion device for growing and maintaining hepatocytes | |
| EP0006192B1 (en) | Device and procedure for microbiological work | |
| DE2726313B2 (en) | Process for the in vitro biosynthesis of hormones, in particular of insulin | |
| EP2410339B1 (en) | Method for the detection of acid production by cariogenic bacteria | |
| DE2320946B2 (en) | Device for microbiological work | |
| EP1066403A1 (en) | Method for detecting micro-organisms in gases | |
| DE2608601B2 (en) | Means for the release of viable microorganisms | |
| DE3504715A1 (en) | METHOD AND MEDIUM FOR PROMOTING PROTEIN PRODUCTION OF SUCTION CELLS | |
| DE2759342C3 (en) | Device for mechanical and chemical stabilization of biologically active compounds with a film-forming stabilizer and for carrying out biological tests | |
| DE2432049A1 (en) | COMPOSITE OF MEMBRANE FILTERS AND POROESE MATERIAL AND ITS USE | |
| DE19738643C2 (en) | Transdermal therapeutic system with the active ingredient scopolamine base and process for its preparation | |
| DE2060121A1 (en) | Enzyme preparation | |
| DE2158827C3 (en) | Means for quality assessment of microbiological growth media | |
| EP1019179A1 (en) | Gelatine membrane filters and method for producing the same | |
| DE3226320C2 (en) | ||
| EP0651788B1 (en) | Process for co-cultivating a type of cells with liver cells | |
| US4042733A (en) | Forming solid, adhesive-free composite of membrane filters and cellulosic cardboard | |
| DE2301211C3 (en) | Synthetic nutrient medium for microorganisms | |
| DE10062623B4 (en) | Three-dimensional skin model | |
| DE2106154C3 (en) | Process for the production of a lactic acid bacteria preparation | |
| DE1173640B (en) | Process for the production of membrane filters | |
| EP0456792B1 (en) | IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BHN | Withdrawal |